Hareth A Al-Wassiti (Hareth Al-Wassiti)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Atomic Force Microscopy

Respiratory Syndrome Coronavirus

Top Venues

Biomacromolecules

Molecular pharmaceutics

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Xie He, Thomas J Payne, Asuka Takanashi, Yunji Fang, Simran D Kerai, Joshua P Morrow, Hareth A Al-Wassiti, Colin W Pouton, Kristian Kempe
Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles. Biomacromolecules (2024)
Xie He, Thomas J Payne, Asuka Takanashi, Yunji Fang, Simran D Kerai, Joshua P Morrow, Hareth A Al-Wassiti, Colin W Pouton, Kristian Kempe
Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles. Biomacromolecules 25 (7) (2024)
Asuka Takanashi, Colin W Pouton, Hareth A Al-Wassiti
Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection. Molecular pharmaceutics (2023)
Hareth A Al-Wassiti, David R Thomas, Kylie M Wagstaff, Stewart A Fabb, David A Jans, Angus P Johnston, Colin W Pouton
Adenovirus Terminal Protein Contains a Bipartite Nuclear Localisation Signal Essential for Its Import into the Nucleus. International journal of molecular sciences 22 (7) (2021)
Danijela Zukancic, Estelle J A Suys, Emily H Pilkington, Azizah Algarni, Hareth A Al-Wassiti, Nghia Phuoc Truong
The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles. Pharmaceutics 12 (11) (2020)